Log In
BCIQ
Print this Print this
 

Lansoprazole/aspirin (Takelda)

  Manage Alerts
Collapse Summary General Information
Company Takeda Pharmaceutical Co. Ltd.
DescriptionFixed-dose combination of lansoprazole and low-dose aspirin
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule: Combination
Latest Stage of DevelopmentMarketed
Standard IndicationGastric ulcers
Indication DetailsPrevent recurrence of ulcers in patients who require administration of low-dose aspirin
Regulatory Designation Japan - Standard Review (Prevent recurrence of ulcers in patients who require administration of low-dose aspirin)
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today